Company Filing History:
10 out of 15,471 
1 out of 1,765 
1 out of 902 Years Active: 1994-2024
Title: **Innovator Kenneth J. Shea: Pioneering Advances in Nanomedicine**
Introduction
Kenneth J. Shea, a distinguished inventor based in Irvine, California, has made significant contributions to the field of nanomedicine. With a portfolio of 13 patents, Shea is at the forefront of developing innovative materials and methods aimed at addressing critical health challenges, particularly in cancer treatment and diagnosis.
Latest Patents
Among Kenneth J. Shea's most notable recent inventions is the abiotic anti-VEGF nanoparticle. This invention provides a groundbreaking approach to develop compositions and methods that utilize abiotic, synthetic polymers designed for their affinity and specificity to proteins, especially the vascular endothelial growth factor (VEGF). The implications of this invention are profound, as it offers a streamlined, less expensive, and customizable platform for binding to proteins. The applications range from treating diseases associated with VEGF overexpression, such as cancer, to diagnosing these conditions by detecting VEGF levels in biological samples.
Additionally, Shea has developed protein-polymer hybrid biomaterials suitable for drug delivery applications. His work on stimuli-responsive cross-linked hydrogels represents a significant advance, responding to specific metabolites within tumor microenvironments—positioning these materials to release therapeutic agents in response to elevated lactate concentrations typically found in tumors. This innovative perspective enhances the efficacy of drug delivery systems in oncology.
Career Highlights
Kenneth J. Shea's career includes key roles at reputable institutions, including the University of California and Sandia Corporation. His work in these organizations has laid the groundwork for his cutting-edge inventions and has reinforced his status as a prominent figure in the field of materials science and biomedicine.
Collaborations
Throughout his career, Shea has collaborated with notable colleagues, including Yu Hoshino and Stephen T. Hobson. Their joint efforts have further fueled the advancements in their collective research, leading to valuable contributions within the realm of nanotechnology and polymer science.
Conclusion
Kenneth J. Shea embodies the spirit of innovation and dedication in addressing complex medical challenges through the power of synthetic materials and nanomedicine. With his impressive track record of patents and collaborations, Shea continues to pave the way for future breakthroughs that could significantly transform cancer treatment and diagnostics, demonstrating the vital role of inventors in advancing health science.